跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,997 条关于
“central precocious puberty”
全部
28,997
临床试验
23,874
药物
194
机构
771
资讯
4,158
去年
Foresee Pharmaceuticals Completes Enrollment in Phase 3 Trial for Central Precocious Puberty Treatment
10个月前
Debiopharm Completes Enrollment for First-Ever Yearly Injectable Triptorelin Formulation in Pediatric Central Precocious Puberty Trial
去年
DSMB Endorses Safety of Foresee's CAMCEVI in Pediatric Precocious Puberty Trial
8个月前
Foresee Pharmaceuticals Licenses MMP-12 Inhibitor Portfolio to Primevera Therapeutics in $584.5 Million Deal
去年
Foresee Pharmaceuticals' Leuprolide (FP-001) Receives Positive DSMB Recommendation for CPP Phase 3 Trial
去年
CSPC Pharma's Leuprorelin Injection and Regorafenib Tablets Approved for Clinical Trials and Treatment in China
10个月前
AbbVie's LUPRON DEPOT Receives Health Canada Approval for New 6-Month Dosing Option in Advanced Prostate Cancer
去年
FDA Approves Foresee's CAMCEVI ETM 21mg for Advanced Prostate Cancer Treatment
去年
NHS Launches £10 Million Clinical Trial on Puberty Blockers Following Cass Review Recommendations
去年
UK Clinical Trial Aims to Resolve Debate on Puberty Blockers for Gender Dysphoria
第 1 页，共 416 页
上一页
下一页
